Philipp Aigner, Theodor Abart, Thomas Schwab, Kamen Dimitrov, Erhan Urganci, Manar El-Shaer, Michael Roehrich, Daniel Zimpfer, Marcus Granegger
Clinical evidence indicates that myocardial recovery during left ventricular assist device (LVAD) therapy is influenced by mechanical unloading. Strategies restoring physiological ventriculo-arterial (VA) coupling may promote recovery. Therefore, this study investigated whether rotodynamic blood pumps (RBP) operated in modulated rotational speed can optimize ventriculo-pump-arterial (VpA) coupling and improve mechano-energetic performance. VpA coupling was assessed using a hybrid mock loop simulating a virtual 30-kg pediatric patient under moderate and end-stage heart failure (HF). Constant-speed operation, symmetric pulsatile profiles (sinusoidal and step), and an asymmetric step profile (30%/70% high/low speed duration) were tested at varying phase delays after systole onset. Key findings were validated in an isolated large-animal heart model, including analysis of VA/VpA coupling and cardiac efficiency. Constant speed LVAD support worsened VpA coupling (moderate HF: 1.50 to 1.79; end-stage HF: 4.19 to 7.67). In contrast, symmetric pulsatile profiles during copulsation improved coupling (moderate HF: sine/step 1.32/0.97; end-stage HF: sine/step 3.30/2.52) and arterial pressure pulsatility (moderate HF: sine/step +40%/+74%; end-stage HF: sine/step +132%/+225%) but caused significant diastolic backflow. The asymmetric step profile maintained improved matching (moderate/end-stage HF: 0.97/2.86) and arterial pulsatility (+58%/+174%) while reducing backflow. Isolated heart experiments confirmed improved coupling, arterial pulsatility and maximized cardiac efficiency at optimized phayse delays (70-90% delay). Cardiac cycle synchronized operation of RBPs in co-pulsation improves VpA coupling, cardiac efficiency and arterial pulsatility compared with constant-speed support. Tailoring pulsatile profiles to cardiac timing and residual function may enable more physiological support and promote recovery-oriented LVAD therapy.